Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Sign Up to like & getrecommendations! Published in 2024 at "Blood Cancer Journal"
DOI: 10.1038/s41408-024-01081-z
Abstract: Three classes of BCMA-directed therapy (BDT) exist: antibody drug-conjugates (ADCs), CAR-T, and T-cell engagers (TCEs), each with distinct strengths and weaknesses. To aid clinicians in selecting between BDTs, we reviewed myeloma patients treated at Mayo… read more here.
Keywords: prior bdt; bcma directed; adcs car; features associated ... See more keywords